v3.21.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Revenues
Operating expenses:    
Research and development 2,654,772 1,449,872
General and administrative 1,358,679 1,831,621
Total operating expenses 4,013,451 3,281,493
Operating loss (4,013,451) (3,281,493)
Other income (expense):    
Interest income 3,173 35,449
Interest expense (14,560) (77,836)
Equity modification expense   (802,400)
Amortization of debt discount and offering costs (13,506) (91,283)
Total other expense (24,893) (936,070)
Net loss $ (4,038,344) $ (4,217,563)
Basic and diluted net loss per share (in Dollars per share) $ (0.07) $ (0.10)
Weighted average common shares outstanding - basic and diluted (in Shares) 61,560,279 43,119,369

Source